Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: May 31, 2023. (Total: 217454Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Colorectal Neoplasms and IGF1R[original query]
Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Nov 16 (22): 5591-602.
Winder Thomas, Zhang Wu, Yang Dongyun, Ning Yan, Bohanes Pierre, Gerger Armin, Wilson Peter M, Pohl Alexandra, Mauro David J, Langer Christiane, Rowinsky Eric K, Lenz Heinz-Jos
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
Clinical colorectal cancer 2011 Dec 10 (4): 325-32.
Inno Alessandro, Di Salvatore Mariantonietta, Cenci Tonia, Martini Maurizio, Orlandi Armando, Strippoli Antonia, Ferrara Anna Maria, Bagalà Cinzia, Cassano Alessandra, Larocca Luigi Maria, Barone Car
Association of insulin-like growth factor-I receptor polymorphism with colorectal cancer development.
Molecular biology reports 2014 Dec 41 (12): 8099-106.
Stanilov Noyko S, Karakolev Iliya A, Deliysky Tashko S, Jovchev Jovcho P, Stanilova Spaska
Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status.
PloS one 2014 9 (8): e103551.
Lee Jeeyun, Jain Anjali, Kim Phillip, Lee Tani, Kuller Anne, Princen Fred, In-GuDo , Kim Suk Hyeong, Park Joon Oh, Park Young Suk, Singh Sharat, Kim Hee Che
Questioning the IGF1 receptor's assigned role in CRC - a case for rehabilitation?
BMC cancer 2020 7 20 (1): 704.
Heckl Steffen M, Pellinghaus Marie, Behrens Hans-Michael, Krüger Sandra, Schreiber Stefan, Röcken Christo
Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy.
JCO precision oncology 2022 5 6 e2200037.
Randon Giovanni, Maddalena Giulia, Germani Marco Maria, Pircher Chiara Carlotta, Manca Paolo, Bergamo Francesca, Giordano Mirella, Sposetti Caterina, Montagna Aldo, Vetere Guglielmo, Zambelli Luca, Rasola Cosimo, Boccaccino Alessandra, Pagani Filippo, Ambrosini Margherita, Massafra Marco, Fontanini Gabriella, Milione Massimo, Fassan Matteo, Cremolini Chiara, Lonardi Sara, Pietrantonio Filip
TOP